2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine

C112H117F6N25Pt4 — CID 158421616

IUPAC2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine
SMILESCC(C)(C)c1cc(-c2cc(-c3cc(C(C)(C)C)n[n-]3)nc(-c3cc(C(C)(C)C)n[n-]3)c2)cc(C(C)(C)C)c1.CC(C)(C)c1cc(-c2cc3ccccc3c(-c3[n-]nc4c3CCCC4(C)C)n2)[n-]n1.CC(C)(C)c1ccncc1.Cc1cc[c-]cc1.Cn1ccnc1-c1[c-]c(-c2nccn2C)cnc1.FC(F)(F)c1n[n-]c(-c2cccc(-c3nc(C(F)(F)F)n[n-]3)n2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2cnccc2c1.c1ccncc1
InChIInChI=1S/C33H43N5.C25H27N5.C13H12N5.C11H3F6N7.C9H7N.C9H13N.C7H7.C5H5N.4Pt/c1-30(2,3)22-13-20(14-23(17-22)31(4,5)6)21-15-24(26-18-28(37-35-26)32(7,8)9)34-25(16-21)27-19-29(38-36-27)33(10,11)12;1-24(2,3)20-14-19(27-28-20)18-13-15-9-6-7-10-16(15)21(26-18)22-17-11-8-12-25(4,5)23(17)30-29-22;1-17-5-3-15-12(17)10-7-11(9-14-8-10)13-16-4-6-18(13)2;12-10(13,14)8-19-6(21-23-8)4-2-1-3-5(18-4)7-20-9(24-22-7)11(15,16)17;1-2-4-9-7-10-6-5-8(9)3-1;1-9(2,3)8-4-6-10-7-5-8;1-7-5-3-2-4-6-7;1-2-4-6-5-3-1;;;;/h13-19H,1-12H3;6-7,9-10,13-14H,8,11-12H2,1-5H3;3-6,8-9H,1-2H3;1-3H;1-7H;4-7H,1-3H3;3-6H,1H3;1-5H;;;;/q2*-2;-1;-2;;;-1;;4*+2
InChIKeyFUPJULDKXFULPX-UHFFFAOYSA-N
MW2707.64 g/mol
LogP24.27
Rot. Bonds9

About 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine

2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine (PubChem CID 158421616) has the molecular formula C112H117F6N25Pt4 and a molecular weight of 2707.64 g/mol. Its IUPAC name is 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine.

Molecular Properties

Compound Name2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine
PubChem CID158421616
Molecular FormulaC112H117F6N25Pt4
Molecular Weight2707.64 g/mol
Exact Mass2705.84
IUPAC Name2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine
SMILESCC(C)(C)c1cc(-c2cc(-c3cc(C(C)(C)C)n[n-]3)nc(-c3cc(C(C)(C)C)n[n-]3)c2)cc(C(C)(C)C)c1.CC(C)(C)c1cc(-c2cc3ccccc3c(-c3[n-]nc4c3CCCC4(C)C)n2)[n-]n1.CC(C)(C)c1ccncc1.Cc1cc[c-]cc1.Cn1ccnc1-c1[c-]c(-c2nccn2C)cnc1.FC(F)(F)c1n[n-]c(-c2cccc(-c3nc(C(F)(F)F)n[n-]3)n2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2cnccc2c1.c1ccncc1
InChIInChI=1S/C33H43N5.C25H27N5.C13H12N5.C11H3F6N7.C9H7N.C9H13N.C7H7.C5H5N.4Pt/c1-30(2,3)22-13-20(14-23(17-22)31(4,5)6)21-15-24(26-18-28(37-35-26)32(7,8)9)34-25(16-21)27-19-29(38-36-27)33(10,11)12;1-24(2,3)20-14-19(27-28-20)18-13-15-9-6-7-10-16(15)21(26-18)22-17-11-8-12-25(4,5)23(17)30-29-22;1-17-5-3-15-12(17)10-7-11(9-14-8-10)13-16-4-6-18(13)2;12-10(13,14)8-19-6(21-23-8)4-2-1-3-5(18-4)7-20-9(24-22-7)11(15,16)17;1-2-4-9-7-10-6-5-8(9)3-1;1-9(2,3)8-4-6-10-7-5-8;1-7-5-3-2-4-6-7;1-2-4-6-5-3-1;;;;/h13-19H,1-12H3;6-7,9-10,13-14H,8,11-12H2,1-5H3;3-6,8-9H,1-2H3;1-3H;1-7H;4-7H,1-3H3;3-6H,1H3;1-5H;;;;/q2*-2;-1;-2;;;-1;;4*+2
InChIKeyFUPJULDKXFULPX-UHFFFAOYSA-N
XLogP24.27
TPSA313.59 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds9
Heavy Atoms147
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002707.64
LogP ≤ 524.27
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine?
The IUPAC name of 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine (CID 158421616) is 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine.
What is the SMILES notation for 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine?
The canonical SMILES for 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine is CC(C)(C)c1cc(-c2cc(-c3cc(C(C)(C)C)n[n-]3)nc(-c3cc(C(C)(C)C)n[n-]3)c2)cc(C(C)(C)C)c1.CC(C)(C)c1cc(-c2cc3ccccc3c(-c3[n-]nc4c3CCCC4(C)C)n2)[n-]n1.CC(C)(C)c1ccncc1.Cc1cc[c-]cc1.Cn1ccnc1-c1[c-]c(-c2nccn2C)cnc1.FC(F)(F)c1n[n-]c(-c2cccc(-c3nc(C(F)(F)F)n[n-]3)n2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2cnccc2c1.c1ccncc1.
What is the InChIKey of 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine?
The InChIKey is FUPJULDKXFULPX-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H43N5.C25H27N5.C13H12N5.C11H3F6N7.C9H7N.C9H13N.C7H7.C5H5N.4Pt/c1-30(2,3)22-13-20(14-23(17-22)31(4,5)6)21-15-24(26-18-28(37-35-26)32(7,8)9)34-25(16-21)27-19-29(38-36-27)33(10,11)12;1-24(2,3)20-14-19(27-28-20)18-13-15-9-6-7-10-16(15)21(26-18)22-17-11-8-12-25(4,5)23(17)30-29-22;1-17-5-3-15-12(17)10-7-11(9-14-8-10)13-16-4-6-18(13)2;12-10(13,14)8-19-6(21-23-8)4-2-1-3-5(18-4)7-20-9(24-22-7)11(15,16)17;1-2-4-9-7-10-6-5-8(9)3-1;1-9(2,3)8-4-6-10-7-5-8;1-7-5-3-2-4-6-7;1-2-4-6-5-3-1;;;;/h13-19H,1-12H3;6-7,9-10,13-14H,8,11-12H2,1-5H3;3-6,8-9H,1-2H3;1-3H;1-7H;4-7H,1-3H3;3-6H,1H3;1-5H;;;;/q2*-2;-1;-2;;;-1;;4*+2.
What are the key properties of 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine?
2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine has a molecular weight of 2707.64 g/mol, XLogP of 24.27, 9 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine is sourced from PubChem (CID 158421616), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).